Published on 03/12/2025

Sealer Start-Up & Shutdown Checks: Routine Controls

The pharmaceutical packaging process is a critical component of ensuring the safety, efficacy, and quality of pharmaceutical products. Within this process, the sealer or crimper’s qualification and performance validation become imperative for compliance with regulatory standards, such as the US FDA, EMA, and MHRA guidelines. This step-by-step tutorial will detail the essential components of the sealer start-up and shutdown checks, focusing on aspects such as packaging process validation, sealer crimper qualification, label print verification, and UDI compliance.

Understanding Packaging Process Validation

Packaging process validation is a structured approach to ensuring that a packaging process consistently produces products that meet predetermined specifications and quality attributes. It involves validating each critical aspect of the packaging process to confirm its reliability and reproducibility. Key focus areas in packaging process validation include:

• Sealer crimper qualification
• Heat seal parameters
• Label print verification
• OCR/OCV validation
• UDI compliance
• Line clearance and reconciliation rules

Compliance with standards such as FDA, EMA, and PIC/S is essential to avoid discrepancies and ensure product integrity. Each step of the validation process must be documented and reproducible to meet regulatory expectations.

Sealer/Crimper Qualification

The sealer crimper qualification process is vital for ensuring that the equipment used in packaging products functions effectively. This qualification generally consists of three phases: Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). Each phase serves a distinct purpose:

1. Installation Qualification (IQ): Verifies that the sealer has been installed according to specifications. This includes checking for correct placement, calibration, and adherence to equipment requirements.
2. Operational Qualification (OQ): Assesses the operational efficiency of the sealing equipment under normal operating conditions. Key parameters like pressure, temperature, dwell time, and seal integrity must be validated to meet the established acceptance criteria.
3. Performance Qualification (PQ): Confirms that the equipment consistently performs as intended over an extended period. Typically, this phase involves producing a batch of products and testing them against specific attributes.

Special attention should be given to the documentation of each qualification phase. The records created serve as the basis for continued process verification (CPV) and future audits.

Heat Seal Parameters

Heat seal parameters play a crucial role in the quality and integrity of a sealed package. The key parameters that must be monitored and controlled during the sealing process include:

• Temperature: Optimal sealing temperature should be determined, typically ranging from 130°C to 180°C, depending on the materials being sealed.
• Pressure: Appropriate sealing pressure must be applied to ensure a strong seal. Insufficient pressure can lead to failing seals.
• Dwell Time: The duration for which the heat is applied also affects seal strength. It should be calibrated based on the material and thickness.

Establish a process for the continuous monitoring of these parameters during routine operations. Any deviations should be promptly investigated and documented to maintain compliance with regulatory standards.

Label Print Verification

Labeling compliance is critical in the pharmaceutical industry. Incorrect labeling can lead to significant regulatory issues and product recalls. Therefore, a rigorous label print verification process must be in place. Key activities involved in this process include:

• Visual Inspection: Conduct a visual check on printed labels to ensure compliance with design and specified content. This step should be conducted for each batch.
• OCR/OCV Validation: Utilize Optical Character Recognition (OCR) to confirm that the printed text corresponds with the expected output. OCR techniques provide an efficient way to ensure that details like expiry dates, batch numbers, and UDI compliance are correct.
• Defect Libraries: Maintain libraries of acceptable and unacceptable print defects to help train inspectors and facilitate quick identification during verification.

Utilize an Acceptance Criteria document that outlines how labels should be verified, ensuring that it aligns with ISO/IEC 15416 and 15415 standards for print quality. Regularly scheduled audits can further ensure compliance and readiness for regulatory inspections.

UDI Verification Compliance

Unique Device Identification (UDI) compliance is critical for traceability in pharmaceutical packaging. Procedures must ensure that all packaged products are compliant with UDI regulations. Key steps include:

• Data Integrity: Ensure the accuracy of UDI data in the system prior to printing. This includes checking the device identifier and production identifier against product specifications.
• Printing Quality: Conduct regular assessments of the printed UDI codes for scannability and clarity, ensuring they meet all regulatory requirements.
• Documentation: Maintain comprehensive records of UDI verification processes, including audit trails, to support compliance with regulatory scrutiny.

Prioritize UDI compliance as part of your quality management system (QMS) to avoid risks associated with non-compliance and maintain the integrity of the product lifecycle.

Line Clearance and Reconciliation Rules

Line clearance is the procedure that verifies that a packaging line is free from previous product remnants and that all packaging materials are appropriately segregated before commencing new production runs. A robust line clearance protocol involves several essential steps:

• Physical Inspection: Verify that all previously used materials are removed from the packaging area and that the line is clean and free from contaminants.
• Documentation: Create a checklist to confirm that all packaging materials from the previous run have been reconciled and discarded. This documentation should be completed before the start of any new production.
• Segregation Procedures: Ensure that materials are adequately segregated to prevent cross-contamination and mislabeling.

The implementation of these reconciliation rules will enhance the overall quality control process and reduce the potential for recalls or customer complaints.

Changeovers and Speeds

Changeovers between different products or packaging configurations can pose significant challenges. Effective changeover procedures help mitigate these challenges and ensure efficiency. Key considerations include:

• Standard Operating Procedures (SOPs): Develop clear SOPs for conducting changeovers. These should include step-by-step instructions for minimizing downtime.
• Training: Ensure that all staff involved in the changeover process are adequately trained and familiar with the procedures.
• Monitoring Performance: Regularly analyze the speed and efficiency of the changeover processes to identify opportunities for improvement. This aligns with the principles of continued process verification (CPV) and performance optimization.

By adopting these strategies, pharmaceutical manufacturers can enhance their operational efficiency while meeting rigorous quality standards.

Documenting and Reporting

As with all components of pharmaceutical validation, thorough documentation and reporting are critical. Each step in the sealer start-up and shutdown checks must be documented in detail. Key documentation practices include:

• Record Keeping: Maintain accurate and complete records of all validation activities, checks, and outcomes.
• Electronic Record Systems: Consider employing validated electronic systems for data capturing and reporting to streamline documentation processes and reduce human error.
• Auditing: Implement regular audits of documentation to ensure compliance with regulatory expectations and continual refinement of processes.

Documentation practices must align with regulatory guidance, ensuring transparency and accessibility for audits by agencies such as the FDA and EMA.

Conclusion

The sealer start-up and shutdown checks are essential components of the packaging process validation. By implementing stringent qualification measures, adhering to heat seal parameters, ensuring robust label print verification, and maintaining compliance with UDI guidelines, pharmaceutical organizations can uphold the integrity of their packaging processes. The steps outlined in this tutorial serve as a comprehensive guide for professionals involved in packaging operations, regulatory affairs, and quality assurance, helping them navigate this complex landscape while achieving compliance with international regulations.

The commitment to ongoing validation and process improvement is vital to meeting the standards enforced by FDA, EMA, MHRA, and PIC/S, ensuring the safety and efficacy of pharmaceutical products in the market.